GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/14/2026 5:00:55 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $788,000 | EPS -$0.35 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/14/2026 4:31:54 PM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $788,000 | EPS -$0.35 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/15/2026 5:01:21 PM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $755,000 | EPS -$0.19 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/15/2026 4:45:27 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $755,000 | EPS -$0.19 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/31/2026 5:35:12 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $1,022,000 | EPS -$1.11 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/31/2026 4:17:37 PM | View | Financials | Earnings | SEC | Y 2025 | Assets $1,022,000 | EPS -$0.20 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/14/2025 5:12:37 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $1,380,000 | EPS -$0.19 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/14/2025 4:47:58 PM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $1,380,000 | EPS -$0.19 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/14/2025 8:13:25 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $2,566,000 | EPS -$0.34 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/14/2025 7:51:17 AM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $2,566,000 | EPS -$0.34 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/16/2025 7:02:02 AM | View | Proxy | SEC | Y 2024 | ||||||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/15/2025 5:25:31 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $3,571,000 | EPS -$0.45 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/15/2025 5:08:31 PM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $3,571,000 | EPS -$0.45 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/31/2025 7:44:04 AM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $1,832,000 | EPS -$2.31 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/31/2025 7:11:51 AM | View | Financials | Earnings | SEC | Y 2024 | Assets $1,832,000 | EPS -$0.51 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/14/2024 4:51:26 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $2,025,000 | EPS -$0.51 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/14/2024 4:36:34 PM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $2,025,000 | EPS -$0.51 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/16/2024 7:01:28 AM | View | Proxy | SEC | Y 2023 | ||||||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/14/2024 8:17:52 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $5,683,000 | EPS -$0.04 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/14/2024 7:16:11 AM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $5,683,000 | EPS -$0.04 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/14/2024 5:18:55 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $3,348,000 | EPS -$0.05 | ||
| Brainstorm Cell Therapeutics Inc. (BCLI) | 5/14/2024 4:30:35 PM | View | Financials | Earnings | WIRE | 1Q 2024 | Assets $3,348,000 | EPS -$0.05 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 4/1/2024 9:28:58 AM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $4,208,000 | EPS -$6.00 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 4/1/2024 8:16:20 AM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $3,348,000 | EPS -$0.05 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/14/2023 11:31:29 AM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $5,682,000 | EPS -$0.45 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/14/2023 7:56:03 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $5,682,000 | EPS -$0.45 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/8/2023 5:29:01 PM | View | Proxy | SEC | Y 2022 | ||||||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/14/2023 7:45:47 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $5,747,000 | EPS -$0.13 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/14/2023 7:22:25 AM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $5,747,000 | EPS -$0.13 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/15/2023 7:41:10 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $7,872,000 | EPS -$0.14 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/15/2023 7:17:47 AM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $7,872,000 | EPS -$0.14 | Export Earnings Model | ||
| Brainstorm Cell Therapeutics Inc. (BCLI) | 5/15/2023 7:05:44 AM | View | Financials | Earnings | WIRE | 1Q 2023 | Assets $7,872,000 | EPS -$0.14 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/30/2023 7:38:39 AM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $8,451,000 | EPS -$0.66 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/30/2023 7:20:01 AM | View | Financials | Earnings | SEC | Y 2022 | Assets $8,451,000 | EPS -$0.13 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 12/13/2022 4:06:01 PM | View | Proxy | SEC | Y 2021 | ||||||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/14/2022 7:47:47 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $13,254,000 | EPS -$0.19 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/14/2022 7:17:21 AM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $13,254,000 | EPS -$0.19 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/15/2022 7:49:29 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $18,961,000 | EPS -$0.19 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/15/2022 7:28:05 AM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $18,961,000 | EPS -$0.19 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/16/2022 7:47:02 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $25,791,000 | EPS -$0.15 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/16/2022 7:18:31 AM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $25,791,000 | EPS -$0.15 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/28/2022 7:49:35 AM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $29,277,000 | EPS -$0.68 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/28/2022 7:16:44 AM | View | Financials | Earnings | SEC | Y 2021 | Assets $29,277,000 | EPS -$0.17 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 1/28/2022 4:12:59 PM | View | Conf. Call | SEC | Y 2021 | ||||||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/15/2021 7:14:54 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $34,538,000 | EPS -$0.15 | ||
| Brainstorm Cell Therapeutics Inc. (BCLI) | 11/15/2021 7:07:20 AM | View | Financials | Earnings | WIRE | 3Q 2021 | Assets $34,538,000 | EPS -$0.15 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/4/2021 4:09:36 PM | View | Proxy | SEC | Y 2020 | ||||||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/5/2021 7:22:30 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $42,235,000 | EPS -$0.17 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/5/2021 7:11:13 AM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $42,235,000 | EPS -$0.17 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 4/26/2021 7:21:39 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $48,571,000 | EPS -$0.19 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 4/26/2021 7:06:17 AM | View | Financials | Earnings | SEC | 1Q 2021 | Assets $48,571,000 | EPS -$0.19 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 2/4/2021 7:21:40 AM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $51,259,000 | EPS -$1.07 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 2/4/2021 7:06:37 AM | View | Financials | Earnings | SEC | Y 2020 | Assets $51,259,000 | EPS -$0.37 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 10/15/2020 7:19:42 AM | View | Financials | Earnings | SEC | 3Q 2020 | Assets $32,691,000 | EPS -$0.14 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 10/15/2020 7:11:25 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $32,691,000 | EPS -$0.14 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 10/1/2020 4:53:04 PM | View | Proxy | SEC | Y 2019 | ||||||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/5/2020 7:13:53 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $19,221,000 | |||
| Brainstorm Cell Therapeutics Inc. (BCLI) | 8/5/2020 7:03:45 AM | View | Financials | Earnings | WIRE | 2Q 2020 | Assets $19,221,000 | Export Earnings Model | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/7/2020 6:45:38 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $18,071,000 | |||
| Brainstorm Cell Therapeutics Inc. (BCLI) | 5/7/2020 6:34:00 AM | View | Financials | Earnings | WIRE | 1Q 2020 | Assets $18,071,000 | Export Earnings Model | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 2/18/2020 7:13:00 AM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $6,534,000 | EPS -$1.06 | ||
| Brainstorm Cell Therapeutics Inc. (BCLI) | 2/18/2020 7:01:58 AM | View | Financials | Earnings | WIRE | Y 2019 | Assets $6,534,000 | EPS -$1.06 | Export Earnings Model | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/14/2019 7:06:13 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $7,811,000 | |||
| Brainstorm Cell Therapeutics Inc. (BCLI) | 11/14/2019 6:01:20 AM | View | Financials | Earnings | WIRE | 3Q 2019 | Assets $7,811,000 | Export Earnings Model | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 10/25/2019 5:03:37 PM | View | Proxy | SEC | Y 2018 | ||||||
| Brainstorm Cell Therapeutics Inc. (BCLI) | 8/13/2019 9:05:38 AM | View | Financials | Earnings | WIRE | 2Q 2019 | Assets $8,864,000 | Export Earnings Model | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/13/2019 6:15:29 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $8,864,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/10/2019 5:19:24 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $11,851,000 | |||
| Brainstorm Cell Therapeutics Inc. (BCLI) | 5/10/2019 5:01:38 PM | View | Financials | Earnings | WIRE | 1Q 2019 | Assets $11,851,000 | Export Earnings Model | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 4/1/2019 3:52:05 PM | Micro | View | Financials | 10-K/A | SEC | Y 2018 ending: 12/31/2018 | Assets $11,228,000 | EPS -$0.70 | ||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/29/2019 5:18:11 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Assets $11,228,000 | EPS -$0.70 | ||
| Brainstorm Cell Therapeutics Inc. (BCLI) | 10/29/2018 8:31:47 AM | View | Financials | Earnings | WIRE | 3Q 2018 | Assets $13,769,000 | Export Earnings Model | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 10/29/2018 6:12:43 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $13,769,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 10/10/2018 8:01:44 AM | View | Proxy | SEC | Y 2017 | ||||||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 7/23/2018 8:16:01 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $21,020,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/14/2018 8:07:43 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Assets $9,413,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/8/2018 6:16:40 AM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Assets $11,423,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 10/17/2017 9:14:27 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Assets $11,335,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 9/14/2017 4:10:37 PM | View | Proxy | SEC | Y 2016 | ||||||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/14/2017 4:45:06 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Assets $8,001,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/15/2017 7:11:52 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $9,032,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/29/2017 4:02:10 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Assets $10,766,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/14/2016 5:40:23 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Assets $11,722,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/11/2016 9:25:30 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Assets $13,154,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/11/2016 9:25:01 AM | View | Financials | Earnings | SEC | 2Q 2016 | Assets $13,154,000 | Export Earnings Model | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/11/2016 8:29:41 AM | View | Proxy | SEC | Y 2015 | ||||||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/10/2016 1:31:22 PM | View | Financials | Earnings | SEC | 1Q 2016 | Assets $13,814,000 | Export Earnings Model | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/10/2016 7:54:22 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Assets $13,814,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/10/2016 4:06:19 PM | View | Financials | Earnings | SEC | Y 2015 | Assets $17,080,000 | Export Earnings Model | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/9/2016 4:43:35 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Assets $17,080,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/16/2015 4:19:00 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Assets $18,359,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/13/2015 11:15:52 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Assets $20,363,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/13/2015 9:59:07 AM | View | Financials | Earnings | SEC | 2Q 2015 | Assets $20,363,000 | Export Earnings Model | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 7/17/2015 6:01:56 AM | View | Proxy | SEC | Y 2014 | ||||||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/14/2015 4:33:11 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Assets $22,387,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/14/2015 7:15:32 AM | View | Financials | Earnings | SEC | 1Q 2015 | Assets $22,387,000 | Export Earnings Model | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/26/2015 4:30:31 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Assets $9,911,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/26/2015 3:53:40 PM | View | Financials | Earnings | SEC | Y 2014 | Assets $9,911,000 | Export Earnings Model | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/13/2014 12:21:10 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Assets $11,400,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/13/2014 7:21:53 AM | View | Financials | Earnings | SEC | 3Q 2014 | Assets $11,400,000 | Export Earnings Model | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/12/2014 11:32:46 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Assets $12,524,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 7/22/2014 9:48:00 AM | View | Proxy | SEC | Y 2013 | ||||||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/13/2014 4:07:41 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Assets $4,193,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/27/2014 12:44:15 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Assets $4,726,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/14/2013 4:19:19 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Assets $6,212,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/14/2013 1:46:15 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Assets $3,794,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 5/9/2013 8:20:31 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Assets $4,752,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/15/2013 9:00:30 AM | View | Proxy | SEC | Y 2012 | ||||||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 3/14/2013 8:56:51 AM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Assets $5,138,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 11/13/2012 9:20:03 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Assets $5,721,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | 8/29/2012 9:56:00 AM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2012 ending: 6/30/2012 | Assets $1,850,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC (BCLI) | 5/11/2012 4:53:09 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Assets $2,249,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC (BCLI) | 5/7/2012 4:37:20 PM | View | Proxy | SEC | Y 2011 | ||||||
| BRAINSTORM CELL THERAPEUTICS INC (BCLI) | 3/15/2012 4:26:11 PM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Assets $2,744,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC (BCLI) | 11/14/2011 3:09:39 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Assets $3,245,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC (BCLI) | 9/7/2011 4:26:31 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2011 ending: 6/30/2011 | Assets $3,617,000 | |||
| BRAINSTORM CELL THERAPEUTICS INC (BCLI) | 4/29/2011 3:03:44 PM | View | Proxy | SEC | Y 2010 | ||||||
| BRAINSTORM CELL THERAPEUTICS INC (BCLI) | 5/3/2010 10:19:13 AM | View | Proxy | SEC | Y 2009 | ||||||
| BRAINSTORM CELL THERAPEUTICS INC (BCLI) | 4/30/2010 5:29:28 PM | View | Proxy | SEC | Y 2009 |